Matthew Stober is an accomplished executive in the biopharmaceutical and medical technology sectors, currently serving as Chief Executive Officer of Abzena since January 2023. Stober holds multiple board member positions, including roles at Atlas Clinical Research, Leiters Health, Istari Oncology, and CastleVax, along with past involvement as a board member at X-Vax Technology, Inc., and Bioventus. Previous senior leadership experience includes serving as Chief Operating Officer at Vyaire Medical and President of Global Operations at Smith & Nephew. Stober's education includes two degrees in Chemical Engineering from Villanova University, enhancing a robust career dedicated to driving innovation and operational excellence in healthcare.